Pharming to present at the Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease Days
Pharming Group N.V. announces that Pharming’s Chief Executive Officer, Sijmen de Vries, and Chief Commercial Officer, Stephen Toor, will attend the Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days, April 3 - 4, 2023 in New York.
Pharming’s CEO and CCO will take part in a fireside chat on April 3 at 15:20 ET /21:20 CEST. Click here to rewatch the webcast and download the presentation slides and transcript below.
Pharming’s CEO and CCO will be available for one-to-one investor meetings during the conference.
For more information about the conference, or to schedule a one-to-one with Pharming’s management team, please contact your Guggenheim representative, or send an email to Pharming’s Investor Relations team to investor@pharming.com.